Lysosomal trafficking mediated by Arl8b and BORC promotes invasion of cancer cells that survive radiation

Ping Hsiu Wu, Yasuhito Onodera, Amato J. Giaccia, Quynh Thu Le, Shinichi Shimizu, Hiroki Shirato, Jin Min Nam

研究成果: 雜誌貢獻文章同行評審

7 引文 斯高帕斯(Scopus)

摘要

Enhanced invasiveness, a critical determinant of metastasis and poor prognosis, has been observed in cancer cells that survive cancer therapy, including radiotherapy. Here, we show that invasiveness in radiation-surviving cancer cells is associated with alterations in lysosomal exocytosis caused by the enhanced activation of Arl8b, a small GTPase that regulates lysosomal trafficking. The binding of Arl8b with its effector, SKIP, is increased after radiation through regulation of BORC-subunits. Knockdown of Arl8b or BORC-subunits decreases lysosomal exocytosis and the invasiveness of radiation-surviving cells. Notably, high expression of ARL8B and BORC-subunit genes is significantly correlated with poor prognosis in breast cancer patients. Sp1, an ATM-regulated transcription factor, is found to increase BORC-subunit genes expression after radiation. In vivo experiments show that ablation of Arl8b decreases IR-induced invasive tumor growth and distant metastasis. These findings suggest that BORC-Arl8b-mediated lysosomal trafficking is a target for improving radiotherapy by inhibiting invasive tumor growth and metastasis.
原文英語
文章編號620
期刊Communications Biology
3
發行號1
DOIs
出版狀態已發佈 - 12月 1 2020

ASJC Scopus subject areas

  • 醫藥(雜項)
  • 生物化學、遺傳與分子生物學 (全部)
  • 農業與生物科學 (全部)

指紋

深入研究「Lysosomal trafficking mediated by Arl8b and BORC promotes invasion of cancer cells that survive radiation」主題。共同形成了獨特的指紋。

引用此